← Medical directoryActive ingredient
Wegovy tablets
Tablet form of oral semaglutide authorised in the European Union (European Commission, 15 July 2026) for weight management in adults with a BMI ≥30, or ≥27 with a weight-related comorbidity. It is available in 1.5, 4, 9 and 25 mg strengths, with 25 mg as the maintenance dose, and is taken once daily on an empty stomach. It is not funded by the Spanish public health system.
Institutional endorsement by Clínica Evolution
Medical guides
Oral semaglutide and levothyroxine: taking Wegovy tablets with Eutirox, metformin and alcohol
Read →Switching from Wegovy injections to tablets: what the product information says and who decides
Read →‘GLP-1 Supreme’, ‘Support’ and GLP-1 drops: what’s in them and why they aren’t medicines
Read →Rybelsus and semaglutide tablets without a prescription or on Amazon: what is being sold and the risks involved
Read →Wegovy and Spain's Seguridad Social: why it isn't funded as tablets or as injections
Read →Rybelsus or oral Wegovy for weight loss: which is authorised for weight management, how they differ and what they cost
Read →Natural GLP-1: which foods and habits raise it, and why there is no ‘natural Ozempic’
Read →How to take Wegovy tablets: on an empty stomach, a sip of water, 30 minutes and what to do about a missed dose
Read →Rybelsus 14 mg is now 9 mg: the new 1.5, 4 and 9 mg doses and their equivalents
Read →How to get a prescription for oral Wegovy in Spain: BMI requirements, steps and timescales
Read →Prescription weight-loss pills in Spain (2026): which ones have evidence, what they cost and how to get them
Read →Ozempic in tablet form: what it's called, how it differs and how to get it in Spain
Read →The Wegovy pill in Spain: price, prescription and how to start
Read →
Keep reading
This entry is for information. Your case requires an individual medical assessment.